Skip to main content
logo
Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.240
0.00 (0.00%)
At close: Aug 5, 2026, 4:00 PM EDT
2.290
+0.050 (2.23%)
After-hours: Aug 5, 2026, 7:47 PM EDT

Acumen Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
162128103222222274
Market Cap Growth
100.82%23.66%-53.52%0.38%-19.03%-
Enterprise Value
64.5542.11-38.789.5144.0479.36
Last Close Price
2.242.111.723.845.406.76

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.851.810.570.831.171.22
P/TBV Ratio
1.571.810.570.701.160.60

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
--0.34---
EV/EBIT Ratio
--0.34---
EV/FCF Ratio
--0.45---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.350.440.160.1100
Net Debt / Equity Ratio
-1.11-1.22-0.78-0.80-0.94-0.86
Net Debt / EBITDA Ratio
0.850.691.253.493.949.92
Net Debt / FCF Ratio
0.920.741.654.945.0310.79
Quick Ratio
4.393.896.2118.7722.7337.74
Current Ratio
4.554.076.4619.0123.0838.60
Return on Equity (ROE)
-143.47%-96.20%-45.60%-22.98%-20.71%-76.44%
Return on Assets (ROA)
-89.38%-68.45%-41.53%-24.13%-21.19%-14.26%
Return on Invested Capital (ROIC)
-954.93%-353.64%-182.50%-151.65%-188.36%-123.68%
Return on Capital Employed (ROCE)
-116.22%-81.41%-44.84%-25.16%-21.86%-14.88%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-1.73%-0.91%-23.46%-19.72%-102.43%-4685.58%
Total Shareholder Return
-1.73%-0.91%-23.46%-19.72%-102.43%-4685.58%
SEC Filings: 10-K · 10-Q